Alkermes plc. (ALKS) stock
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30213% above fair value
$47.89+1.42 (+3.06%)
Close on Nov 11, 2026Market cap $8.03BP/E 126.0Yield –
Alkermes gross margin
Gross margin is gross profit as a percentage of revenue.
Alkermes's gross margin for the twelve months ending Jun 30, 2026 was 84.6%. For fiscal 2025 it was 86.7%, against 84.2% the year before. The highest annual figure on record is 86.7% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 86.7% | +2.4 |
| FY2024 | Dec 31, 2024 | 84.2% | −0.5 |
| FY2023 | Dec 31, 2023 | 84.8% | +4.4 |
| FY2022 | Dec 31, 2022 | 80.4% | −2.8 |
| FY2021 | Dec 31, 2021 | 83.2% | +0.4 |
| FY2020 | Dec 31, 2020 | 82.8% | −1.8 |
| FY2019 | Dec 31, 2019 | 84.6% | +0.7 |
| FY2018 | Dec 31, 2018 | 83.9% | +1.0 |
| FY2017 | Dec 31, 2017 | 82.9% | +0.6 |
| FY2016 | Dec 31, 2016 | 82.3% | +4.4 |
| FY2015 | Dec 31, 2015 | 77.9% | +7.5 |
| FY2013 | Mar 31, 2013 | 70.4% | +3.1 |
| FY2012 | Mar 31, 2012 | 67.3% | −4.8 |
| FY2011 | Mar 31, 2011 | 72.0% | −0.2 |
| FY2010 | Mar 31, 2010 | 72.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 80.2% | −7.1 |
| Q1 FY2026 | Mar 31, 2026 | 84.3% | +0.4 |
| Q4 FY2025 | Dec 31, 2025 | 88.0% | +2.4 |
| Q3 FY2025 | Sep 30, 2025 | 86.9% | +3.6 |
| Q2 FY2025 | Jun 30, 2025 | 87.3% | +2.7 |
| Q1 FY2025 | Mar 31, 2025 | 83.9% | +0.7 |
| Q4 FY2024 | Dec 31, 2024 | 85.6% | +4.1 |
| Q3 FY2024 | Sep 30, 2024 | 83.3% | −0.5 |
| Q2 FY2024 | Jun 30, 2024 | 84.6% | −5.2 |
| Q1 FY2024 | Mar 31, 2024 | 83.3% | +3.5 |
| Q4 FY2023 | Dec 31, 2023 | 81.4% | −0.9 |
| Q3 FY2023 | Sep 30, 2023 | 83.9% | +3.9 |
| Q2 FY2023 | Jun 30, 2023 | 89.8% | +10.9 |
| Q1 FY2023 | Mar 31, 2023 | 79.8% | −0.4 |
| Q4 FY2022 | Dec 31, 2022 | 82.3% | −1.2 |
| Q3 FY2022 | Sep 30, 2022 | 79.9% | −3.2 |
| Q2 FY2022 | Jun 30, 2022 | 78.9% | −3.6 |
| Q1 FY2022 | Mar 31, 2022 | 80.2% | −3.5 |
| Q4 FY2021 | Dec 31, 2021 | 83.5% | −1.2 |
| Q3 FY2021 | Sep 30, 2021 | 83.2% | −0.6 |
| Q2 FY2021 | Jun 30, 2021 | 82.5% | +0.7 |
| Q1 FY2021 | Mar 31, 2021 | 83.7% | +2.9 |
| Q4 FY2020 | Dec 31, 2020 | 84.7% | −4.1 |
| Q3 FY2020 | Sep 30, 2020 | 83.7% | +0.3 |
| Q2 FY2020 | Jun 30, 2020 | 81.8% | −1.7 |
| Q1 FY2020 | Mar 31, 2020 | 80.8% | +1.2 |
| Q4 FY2019 | Dec 31, 2019 | 88.7% | +4.3 |
| Q3 FY2019 | Sep 30, 2019 | 83.4% | −0.7 |
| Q2 FY2019 | Jun 30, 2019 | 83.5% | −2.3 |
| Q1 FY2019 | Mar 31, 2019 | 79.7% | −0.6 |
| Q4 FY2018 | Dec 31, 2018 | 84.4% | −1.6 |
| Q3 FY2018 | Sep 30, 2018 | 84.2% | +0.7 |
| Q2 FY2018 | Jun 30, 2018 | 85.7% | +3.9 |
| Q1 FY2018 | Mar 31, 2018 | 80.2% | +1.3 |
| Q4 FY2017 | Dec 31, 2017 | 86.0% | +2.4 |
| Q3 FY2017 | Sep 30, 2017 | 83.4% | +3.1 |
| Q2 FY2017 | Jun 30, 2017 | 81.8% | – |
| Q1 FY2017 | Mar 31, 2017 | 78.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 83.6% | – |
| Q3 FY2016 | Sep 30, 2016 | 80.3% | – |
See a number that looks wrong?